Scrutica
Financial and operational metadata for Vascular Technology (geographic revenue exposure, segment breakdowns, capital allocation), connected via industry classification mapping to the broader supply chain. Sourced from FactSet and EDGAR.
Corporate intelligence profile for Vascular Technology. Revenue derivation and capital allocation are mapped to evaluate the company's structural role in the broader compute supply chain.
Each hop carries the data source, source URL where available, as-of date, and confidence label inline. Where two sources disagree on a parent, both records are surfaced as alternates; the Investigator does not arbitrate.
Starting entity. The chain walks upward from here through documented parent / subsidiary edges in Scrutica’s ownership substrate.
Chain-of-title terminates at Vascular Technology. No further parent corporation is documented in Scrutica’s substrate; for publicly-listed corporations, ultimate beneficial ownership distributes across public shareholders. For state-owned entities, the chain reaches sovereign authority.